Therefore, a comprehensive understanding of the regulatory mechanism of NKG2D and its ligands plays a very crucial role in the body’s anti-tumor immunity and the prognosis of patients and is also the theoretical basis for the treatment of tumors using the MICA-NKG2D signaling axis in the field of tumor immunology. The gene discussed is MICA; the disease is neoplasm.